* Apyx Medical Corp APYX.OQ reported a quarterly adjusted
loss
of 10 cents per share for the quarter ended in March. The mean
expectation of four analysts for the quarter was for a loss
of 13 cents per share.
* Revenue fell 2.8% to $12.14 million from a year ago;
analysts
expected $10.87 million.
* Apyx Medical Corp's reported EPS for the quarter was a
loss
of 10 cents.
* The mean earnings estimate of analysts had risen by
about 18.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Apyx Medical Corp shares had risen by 20.8% this
quarter and
gained 48.7% so far this year.
* The company reported a quarterly loss of $3.48 million.
* Wall Street's median 12-month price target for Apyx
Medical Corp
is $7.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data May
11 at 01:31 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2023 -0.13 -0.10 Beat
Dec. 31 2022 -0.14 -0.17 Missed
Sep. 30 2022 -0.14 -0.17 Missed
Jun. 30 2022 -0.19 -0.16 Beat